by admin | Jul 19, 2025 | The Doctor's Dose
Why VWAP Influences Price Behavior In the fast-paced world of intraday trading, the Volume Weighted Average Price—or VWAP—acts as a magnetic line on the chart, pulling price toward it, repelling it, or serving as a pivot point for key decision-making. But what exactly...
by ADRIAN MANZ | Jul 18, 2025 | The Doctor's Dose
Copper Tariff Shocks Markets: How Investors Can Play the Surge and Brace for the Risks Copper is surging—and not just on fundamentals. President Donald Trump’s July 8 announcement of a 50% tariff on imported copper has jolted the market, sending prices to an all-time...
by ADRIAN MANZ | Jul 18, 2025 | The Doctor's Dose
Netflix Q2 2025 Earnings Beat Forecasts: Revenue Surges 16% as Streamer Raises Guidance Netflix (NASDAQ: NFLX) delivered a robust second-quarter earnings report on Thursday, exceeding Wall Street expectations and signaling continued momentum in both subscriber and ad...
by ADRIAN MANZ | Jul 17, 2025 | The Doctor's Dose
How to Prompt AI for Better Financial Advice: What Investors Need to Know Artificial intelligence is reshaping the way we research stocks, analyze sectors, and make investment decisions. However, when it comes to prompting AI for financial advice, many retail...
by ADRIAN MANZ | Jul 16, 2025 | The Doctor's Dose
AI Boom or Bubble? What the Dot-Com Era Teaches Us About Today’s Market History doesn’t repeat—but as Mark Twain famously noted, it often rhymes. With the AI stock bubble vs dot-com bubble debate heating up, investors are drawing parallels between today’s...
by ADRIAN MANZ | Jul 16, 2025 | The Doctor's Dose
Trump’s Threat to Fire Powell Rattles Markets and Sparks Fears Over Fed Independence By Adrian Manz Markets sent a strong signal Wednesday: tampering with Federal Reserve independence comes with consequences. When President Donald Trump floated the idea of firing Fed...
by ADRIAN MANZ | Jul 16, 2025 | The Doctor's Dose
Tariff-Driven Rally May Be Topping Out—Time to Take Profits or Go Short? Markets have surged in recent months on the back of easing tariff tensions—but that rally may be running out of steam. For active traders and tactical investors, this could be a prime opportunity...
by ADRIAN MANZ | Jul 15, 2025 | The Doctor's Dose
By Adrian Manz | TraderInsight.com The global weight-loss drug market—dominated by U.S. giants Eli Lilly and Novo Nordisk—is facing a potential shake-up, and traders should take note. On Tuesday morning, Jiangsu-based Hengrui Pharma and its U.S. partner Kailera...
by ADRIAN MANZ | Jul 10, 2025 | The Doctor's Dose
Tesla’s Robo-Taxi Rollout: What’s Next for the Self-Driving Future—and the Stock? Tesla’s long-awaited robo-taxi service is no longer a concept—it’s now a live experiment, and investors are watching every move. The company quietly launched its autonomous ride-hailing...
by ADRIAN MANZ | Jul 7, 2025 | The Doctor's Dose
Trump Tariff Threats Shake Market Confidence Wall Street stumbled on Monday as Trump tariff threats returned to the headlines, unsettling markets that had just climbed to fresh record highs. The Dow Jones Industrial Average dropped 422 points, or 0.94%, while the...
